Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy

Abstract

In India, antiretroviral therapy will lead to major survival benefits and is cost-effective by World Health Organization criteria. The availability of second-line regimens will further increase survival, but their cost-effectiveness depends on their relative cost compared with first-line regimens.